Cargando…
Paired CRISPR/Cas9 Nickases Mediate Efficient Site-Specific Integration of F9 into rDNA Locus of Mouse ESCs
Hemophilia B (HB) is an X-linked recessive bleeding disorder, caused by F9 gene deficiency. Gene therapy combined with the CRISPR/Cas9 technology offers a potential cure for hemophilia B. Now the Cas9 nickase (Cas9n) shows a great advantage in reducing off-target effect compared with wild-type Cas9....
Autores principales: | Wang, Yanchi, Zhao, Junya, Duan, Nannan, Liu, Wei, Zhang, Yuxuan, Zhou, Miaojin, Hu, Zhiqing, Feng, Mai, Liu, Xionghao, Wu, Lingqian, Li, Zhuo, Liang, Desheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213315/ https://www.ncbi.nlm.nih.gov/pubmed/30301136 http://dx.doi.org/10.3390/ijms19103035 |
Ejemplares similares
-
ssODN-Mediated In-Frame Deletion with CRISPR/Cas9 Restores FVIII Function in Hemophilia A-Patient-Derived iPSCs and ECs
por: Hu, Zhiqing, et al.
Publicado: (2019) -
Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci
por: Liu, Bo, et al.
Publicado: (2017) -
Correction of F8 intron 1 inversion in hemophilia A patient-specific iPSCs by CRISPR/Cas9 mediated gene editing
por: Hu, Zhiqing, et al.
Publicado: (2023) -
Contracting CAG/CTG repeats using the CRISPR-Cas9 nickase
por: Cinesi, Cinzia, et al.
Publicado: (2016) -
Target-dependent nickase activities of CRISPR-Cas nucleases Cpf1 and Cas9
por: Hua Fu, Becky Xu, et al.
Publicado: (2019)